| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 45.164 | 40.897 | 42.549 | 65.516 | 81.119 | 85.908 | 98.461 | 94.890 | 116.457 | 129.291 |
| Total Income - EUR | 45.170 | 40.919 | 42.549 | 65.516 | 81.119 | 87.978 | 99.474 | 94.893 | 117.068 | 131.592 |
| Total Expenses - EUR | 40.825 | 30.779 | 34.102 | 26.339 | 66.738 | 42.706 | 36.525 | 38.303 | 53.319 | 83.674 |
| Gross Profit/Loss - EUR | 4.345 | 10.140 | 8.447 | 39.177 | 14.381 | 45.271 | 62.949 | 56.590 | 63.750 | 47.918 |
| Net Profit/Loss - EUR | 3.650 | 8.516 | 7.090 | 32.908 | 12.080 | 44.474 | 62.082 | 55.783 | 62.754 | 40.547 |
| Employees | 2 | 0 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 2 |
Check the financial reports for the company - Sabmed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 10.082 | 649 | 638 | 627 | 614 | 603 | 652 | 626 | 596 | 2.689 |
| Current Assets | 83.970 | 102.022 | 108.296 | 133.008 | 42.265 | 61.953 | 90.345 | 63.165 | 107.137 | 57.904 |
| Inventories | 0 | 0 | 0 | 0 | 41.616 | 40.827 | 39.922 | 40.045 | 39.924 | 0 |
| Receivables | 22.398 | 22.169 | 21.794 | 21.394 | 0 | 3.512 | 10.514 | 13.195 | 29.934 | 36.320 |
| Cash | 61.573 | 79.853 | 86.502 | 111.614 | 649 | 17.614 | 39.910 | 9.925 | 37.279 | 21.584 |
| Shareholders Funds | 93.635 | 102.672 | 105.836 | 132.504 | 29.925 | 58.276 | 88.743 | 56.101 | 102.088 | 40.873 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 418 | 0 | 3.099 | 1.131 | 12.954 | 4.280 | 2.254 | 7.691 | 5.646 | 19.720 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Sabmed S.r.l.